L

Lyra Therapeutics

61 employees

Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceuticals and Biotechnology
Wellness
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$101M

from 18 investors over 18 rounds

L

Lyra Therapeutics raised $50M on May 26, 2023

Investors: Armistice Capital LLC, Woodline Partners LP, Samsara BioCapital, Surveyor Capital and Perceptive Advisors

L

Lyra Therapeutics raised $101M on April 8, 2022

Investors: Pura Vida Investments, Perceptive Advisors and Samsara BioCapital

L

Lyra Therapeutics raised $30M on January 29, 2020

Investors: Soleus Capital Management, L.P., Polaris Partners, RA Capital Management, L.P., Intersouth Partners and Perceptive Advisors

L

Lyra Therapeutics raised $30M on September 26, 2018

Investors: Perceptive Advisors, Soleus Capital Management, L.P., RA Capital Management, L.P., Broadview Ventures Inc and Intersouth Partners

FAQ